Supplementary Figure 2 from Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma
Authors:
- Mandana KamgarMandana Kamgar
- G. Aaron HobbsG. Aaron Hobbs
- Raven DavidsonRDRaven Davidson
- Daniel DorbinDDDaniel Dorbin
- Juliannie HerreraJHJuliannie Herrera
- John F. LangenheimJLJohn F. Langenheim
- Rachel A. BurgeRachel A. Burge
- Mohammed AldakkakMAMohammed Aldakkak
- Ryan D. ConrardyRCRyan D. Conrardy
- Aniko SzaboAniko Szabo
- Sam Z. ThaljiSam Z. Thalji
- Bradley MayerBMBradley Mayer
Open Access
- 31 August 2026
- other
- Published by American Association for Cancer Research (AACR)